Effects of dosage titration of methylprednisolone acetate and triamcinolone acetonide on interleukin-1-conditioned equine articular cartilage explants in vitro.

This research investigates the effects of different dosages of two corticosteroids, methylprednisolone acetate (MPA) and triamcinolone acetonide (TA), on the metabolic health of equine cartilage conditioned with interleukin-1alpha. Findings indicate that neither MPA nor TA were less harmful at lower dosages, nor did they effectively counteract the negative effects of interleukin-1alpha on cartilage metabolism.

Research Aims and Hypothesis

• The central aim of this research was to evaluate the metabolic effects of varying dosages of methylprednisolone acetate (MPA) and triamcinolone acetonide (TA) on articular cartilage in horses that had been conditioned with interleukin-1alpha (IL-1), a common protein involved in inflammation.
• The study was based on the assumption that lower dosages of corticosteroids would be less harmful to cartilage metabolism than higher dosages and that TA would cause less harm to cartilage metabolism than MPA.

Methods

• Experimentation was conducted on a variety of treatment groups, consisting of articular cartilage explants with no IL-1 (control), IL-1 alone, and IL-1 plus differing quantities of MPA or TA.
• To assess glycosaminoglycan (GAG) degradation and synthesis, which are critical factors in cartilage health, explants were labelled with 35SO4 before and after the testing period.
• Researchers then analyzed total GAG content in the media and explants as well as total cartilage DNA.

Results

• The use of MPA and TA decreased GAG synthesis in comparison to the control group and the group treated with IL-1 alone.
• All dosages of TA and lower dosages of MPA increased GAG degradation. Unexpectedly, a high dosage of MPA (10 mg/ml) reduced GAG degradation.
• Both MPA and TA increased media GAG content when compared to control and IL-1 explants.
• Total cartilage GAGs were found to be reduced with TA and unchanged with MPA when compared with IL-1 alone.
• Impact on total cartilage DNA was found to be mixed, with MPA decreasing and TA increasing levels in comparison to both IL-1 and control explants.

Conclusions

• Both MPA and TA were ineffective at counteracting the negative effects of IL-1 on cartilage metabolism.
• Lower dosages of MPA and TA were not found to be less harmful to cartilage metabolism than higher dosages, opposing the initial hypothesis.
• Additionally, TA did not appear to be less harmful than MPA on cartilage metabolism.
• The results of this in vitro study differed from those of similar in vivo research, most notably concerning the effects of TA dosage on cartilage. The relatively small number of horses used in the study limited the degree to which these findings can be extrapolated to the broader equine population.